Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Common Stock | Award | $0 | +258K | +373.17% | $0.00 | 327K | Feb 21, 2022 | Direct | F1 |
holding | CVS | Common Stock (By Trust) | 94.4K | Feb 21, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | CVS | Stock Appreciation Rights | 193K | Feb 21, 2022 | Common Stock | 193K | $45.91 | Direct | F2 | |||||
holding | CVS | Stock Appreciation Rights | 94K | Feb 21, 2022 | Common Stock | 94K | $37.91 | Direct | F3 | |||||
holding | CVS | Stock Option | 242K | Feb 21, 2022 | Common Stock | 242K | $54.19 | Direct | F4 | |||||
holding | CVS | Stock Option | 211K | Feb 21, 2022 | Common Stock | 211K | $58.34 | Direct | F5, F6 | |||||
holding | CVS | Stock Option | 225K | Feb 21, 2022 | Common Stock | 225K | $74.30 | Direct | F7 |
Id | Content |
---|---|
F1 | Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan (the "Aetna Plan") on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. |
F2 | Represents unvested Aetna Inc. Stock Appreciation Rights ("SARs") granted under the Aetna Plan on February 17, 2017 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vest in two substantially equal annual installments beginning on February 17, 2019. |
F3 | Represents unvested SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019. |
F4 | Option became exercisable in four equal annual installments, commencing 4/1/2020. |
F5 | The number of shares subject to the option were calculated using a 30-day average price. |
F6 | Options became exercisable in four equal installments, commencing 4/1/2021. |
F7 | Option becomes exercisable in four equal installments, commencing 4/1/2022. |